LncRNA CCAT1 Facilitates the Progression of Gastric Cancer Via PTBP1-mediated Glycolysis Enhancement

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2023 Sep 22

PMID 37740243

Authors

Cong Zhang

Huixia Wang

Qingwei Liu

Suli Dai

Guo Tian

Xintong Wei

Xiaoya Li

Lianmei Zhao

Baoen Shan

Affiliations

Soon will be listed here.

Abstract

Background: Gastric cancer (GC) is one of the most prevalent malignant tumors of the digestive system. As a hallmark of cancer, energy-related metabolic reprogramming is manipulated by multiple factors, including long non-coding RNAs (lncRNAs). Notably, lncRNA CCAT1 has been identified as a crucial regulator in tumor progression. Nevertheless, the precise molecular mechanisms underlying the involvement of CCAT1 in metabolic reprogramming of GC remain unclear.

Methods: Gain- and loss-of-function experiments were performed to evaluate the roles of CCAT1 in tumorigenesis and glycolysis of GC. Bioinformatics analyses and mechanistic experiments, such as mass spectrometry (MS), RNA-pulldown, and RNA immunoprecipitation (RIP), were employed to reveal the potential interacting protein of CCAT1 and elucidate the regulatory mechanism of CCAT1 in GC glycolysis. Moreover, the nude mice xenograft assay was used to evaluate the effect of CCAT1 on GC cells in vivo.

Results: In this study, we identified that CCAT1 expression was significantly elevated in the tissues and plasma exosomes of GC patients, as well as GC cell lines. Functional experiments showed that the knockdown of CCAT1 resulted in a substantial decrease in the proliferation, migration and invasion of GC cells both in vitro and in vivo through decreasing the expression of glycolytic enzymes and glycolytic rate. Conversely, overexpression of CCAT1 exhibited contrasting effects. Mechanistically, CCAT1 interacted with PTBP1 and effectively maintained its stability by inhibiting the ubiquitin-mediated degradation process. As a critical splicing factor, PTBP1 facilitated the transition from PKM1 to PKM2, thereby augmenting the glycolytic activity of GC cells and ultimately fostering the progression of GC.

Conclusions: Our findings demonstrate that CCAT1 plays a significant role in promoting the proliferation, migration, and invasion of GC cells through the PTBP1/PKM2/glycolysis pathway, thus suggesting CCAT1's potential as a biomarker and therapeutic target for GC.

Citing Articles

The role of tumor-derived exosomal LncRNA in tumor metastasis.

Yu Z, Fu J, Mantareva V, Blazevic I, Wu Y, Wen D Cancer Gene Ther. 2025; .

PMID: 40011710 DOI: 10.1038/s41417-024-00852-x.

The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects.

Yuan W, Shi Y, Dai S, Deng M, Zhu K, Xu Y J Transl Med. 2024; 22(1):1142.

PMID: 39719645 PMC: 11667996. DOI: 10.1186/s12967-024-05998-8.

Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis.

Yang S, Lin M, Hao S, Ye H, Zhang X Front Immunol. 2024; 15:1497461.

PMID: 39588377 PMC: 11586341. DOI: 10.3389/fimmu.2024.1497461.

Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy.

Zabeti Touchaei A, Norollahi S, Najafizadeh A, Babaei K, Bakhshalipour E, Vahidi S Cancer Cell Int. 2024; 24(1):334.

PMID: 39369258 PMC: 11453077. DOI: 10.1186/s12935-024-03514-y.

Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key.

Zhang X, Zhang Y, Liu Q, Zeng A, Song L Front Immunol. 2024; 15:1456636.

PMID: 39346921 PMC: 11437524. DOI: 10.3389/fimmu.2024.1456636.

References

Zhao H, Hu S, Qi J, Wang Y, Ding Y, Zhu Q . Increased expression of HOXA11-AS attenuates endometrial decidualization in recurrent implantation failure patients. Mol Ther. 2022; 30(4):1706-1720. PMC: 9077377. DOI: 10.1016/j.ymthe.2022.01.036. View

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

Wang C, Li Y, Yan S, Wang H, Shao X, Xiao M . Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. Nat Commun. 2020; 11(1):3162. PMC: 7308313. DOI: 10.1038/s41467-020-16966-3. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Wang W, Han Y, Jo H, Lee J, Song Y . Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment. J Hematol Oncol. 2020; 13(1):67. PMC: 7275461. DOI: 10.1186/s13045-020-00893-3. View

Kopp F, Mendell J . Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell. 2018; 172(3):393-407. PMC: 5978744. DOI: 10.1016/j.cell.2018.01.011. View

Yang F, Peng Z, Ji W, Yu J, Qian C, Liu J . LncRNA CCAT1 Upregulates ATG5 to Enhance Autophagy and Promote Gastric Cancer Development by Absorbing miR-140-3p. Dig Dis Sci. 2021; 67(8):3725-3741. DOI: 10.1007/s10620-021-07187-9. View

Park E, Pyo S, Cui Y, Yoon S, Nam J . Tumor immune microenvironment lncRNAs. Brief Bioinform. 2021; 23(1). PMC: 8769899. DOI: 10.1093/bib/bbab504. View

Zhao Y, Zhou L, Li H, Sun T, Wen X, Li X . Nuclear-Encoded lncRNA Epigenetically Controls Metabolic Reprogramming in HCC Cells through the Mitophagy Pathway. Mol Ther Nucleic Acids. 2021; 23:264-276. PMC: 7773746. DOI: 10.1016/j.omtn.2020.09.040. View

10.

Wang X, Wei S, Li W, Wei X, Zhang C, Dai S . P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitro. Int Immunopharmacol. 2023; 119:110213. DOI: 10.1016/j.intimp.2023.110213. View

11.

Dai T, Zhang X, Zhou X, Hu X, Huang X, Xing F . Long non-coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer. Clin Transl Med. 2022; 12(10):e1088. PMC: 9561166. DOI: 10.1002/ctm2.1088. View

12.

Yang M, Lu H, Liu J, Wu S, Kim P, Zhou X . lncRNAfunc: a knowledgebase of lncRNA function in human cancer. Nucleic Acids Res. 2021; 50(D1):D1295-D1306. PMC: 8728133. DOI: 10.1093/nar/gkab1035. View

13.

Huan L, Guo T, Wu Y, Xu L, Huang S, Xu Y . Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response. Mol Cancer. 2020; 19(1):11. PMC: 6971890. DOI: 10.1186/s12943-019-1122-z. View

14.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

15.

Clower C, Chatterjee D, Wang Z, Cantley L, Vander Heiden M, Krainer A . The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc Natl Acad Sci U S A. 2010; 107(5):1894-9. PMC: 2838216. DOI: 10.1073/pnas.0914845107. View

16.

Dai S, Wang C, Zhang C, Feng L, Zhang W, Zhou X . PTB: Not just a polypyrimidine tract-binding protein. J Cell Physiol. 2022; 237(5):2357-2373. DOI: 10.1002/jcp.30716. View

17.

Pavlova N, Zhu J, Thompson C . The hallmarks of cancer metabolism: Still emerging. Cell Metab. 2022; 34(3):355-377. PMC: 8891094. DOI: 10.1016/j.cmet.2022.01.007. View

18.

Connerty P, Moles E, de Bock C, Jayatilleke N, Smith J, Meshinchi S . Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia. Pharmaceutics. 2021; 13(10). PMC: 8539450. DOI: 10.3390/pharmaceutics13101681. View

19.

Sharma D, Singh M, Rani R . Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics. Semin Cancer Biol. 2022; 87:184-195. DOI: 10.1016/j.semcancer.2022.11.007. View

20.

Christofk H, Vander Heiden M, Harris M, Ramanathan A, Gerszten R, Wei R . The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008; 452(7184):230-3. DOI: 10.1038/nature06734. View